Home-based Cycling for People With Lumbar Spinal Stenosis
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Aug 29, 2019
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of home-based cycling on people who have lumbar spinal stenosis, a condition that can cause pain in the lower back and legs, especially when walking. The goal is to see if using a special bike at home, combined with regular medical care, helps improve specific back-related activity limitations compared to just receiving standard care.
To participate, individuals need to be at least 50 years old and have been diagnosed with lumbar spinal stenosis, which is often confirmed through imaging tests like an MRI or CT scan. Participants should be able to cycle at home and understand French, as the trial requires communication in that language. Those who have had recent back surgery, have certain severe medical conditions, or cannot engage in the cycling program will not be eligible. If you join the trial, you will be asked to use a connected bike from home for a period of time while receiving regular care, and you will have the chance to see if this approach can help relieve your symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age ≥ 50 year-old
- • radicular claudication (i.e. walking-induced low back, buttock and/or leg pain, relieved in siting and/or lumbar flexion positions) diagnosed by a physician
- • MRI or CT-scan findings consistent with LSS reported on a written radiology report provided by a board-certified radiologist or a resident in radiology
- Exclusion Criteria:
- • inability to speak and/or read French language
- • inability or refusal to perform ergometric bicycle at home
- • patients already having an ergometric bicycle at home
- • history of lumbar spine surgery in the previous 12 months
- • cognitive disorders
- • severe neurologic or vascular disorders involving the lower limbs
- • contraindication to a rehabilitation program assessed by medical examination
- • people under tutorship or curatorship
- • protected adults
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, France
Paris, île De France, France
Patients applied
Trial Officials
Christelle Nguyen, MD, PhD
Principal Investigator
Université de Paris, Faculté de Médecine Paris Descartes
François Rannou, MD, PhD
Study Director
Université de Paris, Faculté de Médecine Paris Descartes
Isabelle Boutron, MD, PhD
Study Chair
Université de Paris, Faculté de Médecine Paris Descartes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials